If the biopharmaceutical R&D people think they are in a bind these days, it's nothing compared to the Western Lady in the Hui Zheng lab at Baylor College of Medicine, "Blot blot, Western baby. Got no bands this shit is crazy."
Showing posts with label biogen idec. Show all posts
Showing posts with label biogen idec. Show all posts
Friday, January 28, 2011
Thursday, November 4, 2010
Biogen Idec walking away from its cancer franchise. What (new drugs) may be lost in shakeup.
Yesterday's big announcement by Biogen Idec to disinvest itself from its cancer franchise (and shut down San Diego site) got me thinking what else was in the pipeline and preclinical programs which may (probably) never see the light of a doctor's office. Was there an Avastin-like blockbuster sitting on a shelf somewhere? Hopefully, some of the programs will be licensed off to someone with deep pockets or belief in it. It can happen here in San Diego and some star molecules may emerge! [...][...]
Labels:
biogen idec,
CD80,
cripto,
Fn14,
galiximab,
raf,
ret,
rituximab,
s1p,
tumor escape,
tumor microenvironment,
tweak,
volociximab
Subscribe to:
Posts (Atom)